Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?

On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire…

Why HoneyBook’s $140M in ARR may finally justify its $2.4B ZIRP-era valuation

HoneyBook, a startup last valued in late 2021 at $2.4 billion, told TechCrunch that it hit…